Jay R. Venkatesan - 12 Feb 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SER	Stock Option (right to buy)	Award	$0	+40,000		$0.000000	40,000	12 Feb 2025	Common Stock	40,000	$4.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock options vest in substantially equal yearly installments beginning on the first anniversary of the grant date such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.